Holen Sie sich die Stockscreener-App
1.44
4.35%
0.06
Finanzdaten der Acumen Pharmaceuticals Inc-Aktie (ABOS)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Revenues |
-
|
- | - | - | - |
Operating Expenses
|
37.47%
41.75
|
30.37 | 39.60 | 32.27 | 24.38 |
| Operating Income/Loss |
37.47%
-41.75
|
-30.37 | -39.60 | -32.27 | -24.38 |
| Nonoperating Income/Loss |
49.17%
0.80
|
1.574 | 2.443 | 2.50 | 3.844 |
| Income/Loss From Continuing Operations Before Tax |
42.21%
-40.95
|
-28.80 | -37.15 | -29.77 | -20.54 |
| Income/Loss From Continuing Operations After Tax |
42.21%
-40.95
|
-28.80 | -37.15 | -29.77 | -20.54 |
|
Net Income/Loss
|
42.21%
-40.95
|
-28.80 | -37.15 | -29.77 | -20.54 |
| Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
| Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
| Basic Average Shares |
0.08%
60.57
|
60.53 | 0.0224 | 60.08 | 60.08 |
| Diluted Average Shares |
0.08%
60.57
|
60.53 | 0.0224 | 60.08 | 60.08 |
| Basic Earnings Per Share |
41.67%
-0.68
|
-0.48 | -0.62 | -0.50 | -0.34 |
| Diluted Earnings Per Share |
41.67%
-0.68
|
-0.48 | -0.62 | -0.50 | -0.34 |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):